DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
Summary
DarioHealth announced an independent Aon analysis showing its Dario platform delivers $5,077 in annual savings and 23.5% fewer inpatient discharges per type 2 diabetes user compared to non-users, with broader evaluation of 17 studies projecting $3.8 million to $10.8 million in annual savings for a 20,000-life population.
Outcome Details
Independent Aon analysis found $5,077 in annual savings per user and 23.5% fewer inpatient discharges for Dario users with type 2 diabetes versus matched non-users. Evaluation of 17 studies estimates $3.8 million to $10.8 million in annual savings for a 20,000-life population with estimated 2.5%-7.2% in-year reduction in total healthcare costs.
Read the original article
Published by PR Newswire Clinical Trials on October 6, 2026 11:30 AM